275 related articles for article (PubMed ID: 4373590)
1. Management of hyperlipidemias.
Murphy BF
JAMA; 1974 Dec 23-30; 230(12):1683-91. PubMed ID: 4373590
[No Abstract] [Full Text] [Related]
2. Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
Levy RI
JAMA; 1973 Nov; 226(6):648-9. PubMed ID: 4356846
[No Abstract] [Full Text] [Related]
3. Dietary and drug treatment of primary hyperlipoproteinemia.
Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
[No Abstract] [Full Text] [Related]
4. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
5. [Familial hyperlipoproteinemia type III].
Patsch JR; Patsch W; Sailer S; Braunsteiner H
Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
[No Abstract] [Full Text] [Related]
6. Type IV hyperlipoproteinaemia.
Kwiterovich PO; Margolis S
Clin Endocrinol Metab; 1973 Mar; 2(1):41-71. PubMed ID: 4359117
[No Abstract] [Full Text] [Related]
7. Xanthomatosis and hyperlipoproteinemia; a review.
Polano MK
Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
[No Abstract] [Full Text] [Related]
8. [Diet therapy in hyperlipoproteinemias].
Canzler H
Z Allgemeinmed; 1974 Jan; 50(2):53-61. PubMed ID: 4361378
[No Abstract] [Full Text] [Related]
9. A physician's guide to hyperlipidemia.
Fredrickson DS
Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098
[No Abstract] [Full Text] [Related]
10. Altering lipid patterns in adult males.
Appelbaum JJ; Amundsen MA; Perkin DK
J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
[No Abstract] [Full Text] [Related]
11. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
Patsch JR; Yeshurun D; Jackson RL; Gotto AM
Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
[No Abstract] [Full Text] [Related]
12. [Treatment of hyperlipoproteinemias (author's transl)].
Crepaldi G; Fellin R; Briani G; Baggio G; Baiocchi MR
G Ital Cardiol; 1974; 4(3):332-40. PubMed ID: 4367439
[No Abstract] [Full Text] [Related]
13. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
[No Abstract] [Full Text] [Related]
14. Dyslipoproteinemias and diabetes mellitus.
Birkbeck JA
Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():79-92. PubMed ID: 4368604
[No Abstract] [Full Text] [Related]
15. [Hyperlipoproteinemia].
Meinders AE
Ned Tijdschr Geneeskd; 1979 Mar; 123(15):617-28. PubMed ID: 219378
[No Abstract] [Full Text] [Related]
16. The treatment of hyperlipidemia.
Lees RS; Wilson DE
N Engl J Med; 1971 Jan; 284(4):186-95. PubMed ID: 4923684
[No Abstract] [Full Text] [Related]
17. The hyperlipoproteinaemias: a review.
Betro MG
N Z Med J; 1972 Mar; 75(478):131-8. PubMed ID: 4337073
[No Abstract] [Full Text] [Related]
18. Secholex, Clofibrate and taurine in hyperlipidaemia.
Howard AN; Evans RJ
Atherosclerosis; 1974; 20(1):105-16. PubMed ID: 4376405
[No Abstract] [Full Text] [Related]
19. Therapy of the hyperlipoproteinemias.
Bagdade JD
Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():98-110. PubMed ID: 4605376
[No Abstract] [Full Text] [Related]
20. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
Weisweiler P; Schwandt P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
